DIFFERENTIAL DIAGNOSIS PROBLEMS OF MALIGNANT LYMPHOMA AND IGG4-RELATED DISEASES WITH LYMPH NODE INVOLVEMENT
https://doi.org/10.29001/2073-8552-2017-32-2-59-61
Abstract
The medical case of IgG4-associated disease with the syndrome of lymphadenopathy and splenomegaly was shown. There is a detailed Literary reference with regard to the problem. The scheme of differential diagnosis is marked. Diagnosis criteria and ways of treatment are given.
About the Authors
G. V. Shamaeva
Novosibirsk State Medical University
Russian Federation
Russian Federation
I. B. Kovynev
Novosibirsk State Medical University
Russian Federation
Russian Federation
I. N. Nechunaeva
City Hematology Center of Municipal City Hospital No. 2
Russian Federation
Russian Federation
L. M. Maslova
City Hematology Center of Municipal City Hospital No. 2
Russian Federation
Russian Federation
M. M. Agakishiev
City Hematology Center of Municipal City Hospital No. 2
Russian Federation
Russian Federation
References
1. Седышев С.Х., Васильев В.И., Ковригина А.М. и др. Заболевание, связанное с IgG4: характеристика группы больных и терапия ритуксимабом // Терапевтический архив. – 2013. – Т. 85, № 2. – С. 48–53.
2. Yoshida K., Toki F., Takeuchi T. et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis // Dig. Dis. Sci. – 2006. – Vol. 40. – P. 1561–1568.
3. Kamisawa T. Is it time to reconsider autoimmune pancreatitis? // J. Gastroenterol. – 2006. – Vol. 41 (12). – P. 1240–1.
4. Ghably J.G., Borthwick T. et al. IgG4-related disease: a primer on diagnosis and management // Annals of Allergy, Asthma & Immunology. – 2015. – Vol. 114, Issue 6. – P. 447–454.
5. Lighaam L.C., Aalberse R.C., Rispens T. IgG4-related fibrotic diseases from an immunological perspective: regulators out of control? // Int. J. Rheumatol. – 2012. – P. 78.
6. Della-Torre E., Lanzillotta M., Doglioni C. Immunology of IgG4-related disease // Clin Exp Immunol. – 2015. – Vol. 181 (2). – P. 191–206.
7. Stone J.H., Zen Y., Deshpande V. IgG4-related disease // N. Engl. J. Med. – 2012. – Vol. 366 (6). – P. 539–51.
8. Yamamoto M., Awakawa T., Takahashi H. Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years // Ann. Rheum. Dis. – 2015. – Vol. 74. – P. 146.
9. Koizumi S., Kamisawa T., Kuruma S. et al. Organ Correlation in IgG4-Related Diseases // J. Korean Med. Sci. – 2015. – Vol. 30 (6). – P. 743–83.
10. Uchida K., Masamune A., Shimosegawa T. et al. The prevalence of IgG4-related disease in Japan, based on a nationwide survey in 2009 // Int. J. Rheumatol. – 2012. – P. 358–371.
11. Okazaki K., Kawa S., Kamisawa T. et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal // J. Gastroenterol. – 2006 – Vol. 41. – P. 626–631.
12. Masaki Y., Sugai S., Umehara H. IgG4-related diseases including Mikulocz’s disease and sclerosing pancreatitis: diagnostic insights // J. Rheumatol. – Vol. 37. – P. 1380–1385.
Review
For citations:
Shamaeva G.V., Kovynev I.B., Nechunaeva I.N., Maslova L.M., Agakishiev M.M. DIFFERENTIAL DIAGNOSIS PROBLEMS OF MALIGNANT LYMPHOMA AND IGG4-RELATED DISEASES WITH LYMPH NODE INVOLVEMENT. Siberian Journal of Clinical and Experimental Medicine. 2017;32(2):59-61. (In Russ.) https://doi.org/10.29001/2073-8552-2017-32-2-59-61
Views:
334
.png)
Email this article 